Iran's nuclear deal pessimism hit markets hard today. Iranian officials demanded uranium enrichment continue. That broke confidence in any near-term US agreement. Oil proxies moved sharply. USO put buying spiked as traders hedged crude upside. Broad-market protection via SPY options also rose. End-of-quarter positioning amplified every move.
Merck and partner Daiichi Sankyo scrapped their FDA application for a lung cancer drug today. The withdrawal removes a key pipeline catalyst for Merck. Short sellers already had 12–15% of Merck's free float committed. Bears and analysts are aligned on caution for the name.
Micron Technology reports Q4 results Wednesday after the close. It is the most market-moving event of the week. The stock is up sharply year-to-date on AI-driven memory demand. Options put buying is the heaviest by volume among large caps going into the print. Analysts hold 44 buy ratings and zero sells — but traders are hedging hard. Days to cover is elevated.
NVIDIA stayed in focus too. CEO Jensen Huang addressed AI risk publicly today, drawing fresh options activity. Negative options bets ranked among the highest by notional value in the US market this week.
Costco saw Deutsche Bank maintain its Buy rating but trim its price target to $1,079. Corteva settled a seed patent lawsuit with Inari today. Inari will destroy Corteva material and assign related IP back. The terms beyond that remain confidential.
Tonight brings results from Vail Resorts and Jefferies Financial Group. Tuesday adds CarMax and Carnival Corporation. The cruise sector update from Carnival carries weight across all leisure travel names.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
